Kymera Therapeutics (KYMR)
(Delayed Data from NSDQ)
$49.79 USD
+0.76 (1.55%)
Updated Sep 20, 2024 03:57 PM ET
After-Market: $49.80 +0.01 (0.02%) 7:48 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.83 | -2.82% |
Earnings Summary
For their last quarter, Kymera Therapeutics (KYMR) reported earnings of -$0.58 per share, beating the Zacks Consensus Estimate of $-0.69 per share. This reflects a positive earnings surprise of 15.94%. Look out for KYMR's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.83 per share, reflecting a year-over-year increase of 7.78%.
Earnings History
Price & Consensus
Zacks News for KYMR
Kymera (KYMR) to Raise $225 Million Through Offering of Shares
KYMR: What are Zacks experts saying now?
Zacks Private Portfolio Services